Sector Focus

Biotechnology

Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.

Clients

CFY BioMedicals, Inc. (later renamed Perlan Therapeutics)

CFY Biomedicals Inc. was an early-stage but rapidly growing biotech company with the mission to develop recombinant protein-based drugs for the prevention and treatment of the common cold.

Search Projects

  • Senior Vice President, Pharmaceutical Development